Cipla | CIPLA - Assets

Stock Price
1,432.10
Daily Change
-4.60 -0.32%
Monthly
16.38%
Yearly
-4.52%
Q2 Forecast
1,401.45

Cipla reported INR401.64B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Arca Biopharma USD 504.48M 15.86M Mar/2026
aTyr Pharma USD 79.65M 435.68M Mar/2026
Bio Path USD 690K 56K Sep/2025
Brainstorm Cell Therapeutics USD 755K 267K Mar/2026
Capricor Therapeutics USD 326.28M 29.66M Mar/2026
Cara Therapeutics USD 32.07M 6.95M Dec/2025
Cipla INR 401.64B 27.77B Sep/2025
Dr.Reddys Laboratories INR 581.23B 18.34B Mar/2026
Esperion Therapeutics USD 462.53M 3.36M Mar/2026
Immunic USD 189.74M 165.69M Mar/2026
Infinity Pharmaceuticals USD 21.23M 8.72M Jun/2023
Minerva Neurosciences USD 97.97M 69.88M Dec/2025
Nektar Therapeutics USD 280.41M 20.94M Dec/2025
Sangamo BioSciences USD 97.56M 11.39M Jun/2025
Sun Pharmaceuticals INR 1.04T 116.06B Sep/2025
TherapeuticsMD USD 40.13M 1.96M Jun/2024
UPL INR 952.05B 38.14B Mar/2026